Form 4 Teladoc Health, Inc. For: Feb 18 Filed by: Jacobson Catherine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Teladoc (TDOC) Shares Down 7% Following Q4 Results and Mixed Outlook
February 22, 2022 5:37 PM ESTTeladoc (NYSE: TDOC) shares were trading around 7% lower after-hours despite the company's reported Q4 results, with EPS of ($0.07) coming in better than the Street estimate of ($0.56). Revenue grew 45% year-over-year to $554.2 million, compared to the Street estimate of $546.6 million. Access fees and visit fee revenues grew 51% and... More
